Integral Health Asset Management’s Natera NTRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-50,000
Closed -$4.57M 95
2024
Q1
$4.57M Sell
50,000
-175,000
-78% -$13.2M 0.42% 67
2023
Q4
$14.1M Buy
225,000
+25,000
+13% +$1.25M 1.92% 16
2023
Q3
$8.85M Buy
+200,000
New +$10.2M 1.23% 33
2023
Q2
Sell
-75,000
Closed -$4.16M 92
2023
Q1
$4.16M Sell
75,000
-12,000
-14% -$576K 0.84% 48
2022
Q4
$3.49M Buy
+87,000
New +$3.58M 0.73% 47
2021
Q4
Sell
-40,000
Closed -$4.46M 80
2021
Q3
$4.46M Sell
40,000
-15,000
-27% -$1.72M 1.28% 29
2021
Q2
$6.24M Buy
55,000
+20,000
+57% +$2.05M 1.72% 24
2021
Q1
$3.55M Sell
35,000
-10,000
-22% -$1.1M 1.02% 39
2020
Q4
$4.48M Sell
45,000
-21,000
-32% -$1.75M 1.33% 29
2020
Q3
$4.77M Buy
+66,000
New +$3.75M 1.46% 24

Other funds holding NTRA

Integral Health Asset Management's NTRA Position: Q2 2024 in Review

Integral Health Asset Management sold out of Natera (NTRA) in Q2 2024, closing a stake of 50,000 shares — an estimated $4.57M sold.

Integral Health Asset Management first reported a position in NTRA in Q3 2020 and held it in 10 quarters. The position peaked at $14.1M in Q4 2023. 475 funds tracked by Wall St. Rank hold NTRA as of Q2 2024.

  • Integral Health Asset Management reported no remaining Natera position as of Q2 2024 after selling out during the quarter.
  • Integral Health Asset Management sold 50,000 Natera shares in Q2 2024, an estimated $4.57M.
  • Integral Health Asset Management first reported a position in Natera in Q3 2020 and held it in 10 quarters.
  • Integral Health Asset Management's Natera position peaked at $14.1M in Q4 2023.
  • 475 funds tracked by Wall St. Rank held Natera as of Q2 2024.

Based on Integral Health Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.